IntelligentMDx is a commercial stage molecular diagnostics company that makes tests that are clinically impactful, competitively differentiated,and platform agnostic.  We have product offerings for Seasonal/Pandemic Influenza, Bordetella, Immunocompromised and Infection Control including antimicrobial resistance screening.   IntelligentMDx commercializes molecular diagnostic test solutions under FDA QSR, ISO 13485:2003 and IVDD regulations and guidances for use in clinical reference laboratories.  More»

 

IntelligentMDx received certification to the ISO 13485:2003 Quality Management Systems standards and guidelines

 


 


IntelligentMDx featured in the November Issue

In Person Trends and Advances In Molecular Diagnostics 
  


 
November 1, 2009

Frost & Sullivan presents IntelligentMDx with the 2009 Healthcare Innovation Award 


Dr. Alice Jacobs describes new influenza test on Fox Business News

View Interview